El diagnóstico in vitro (IVD) abarca un espectro de exámenes y procedimientos médicos realizados con fluidos corporales, tejidos o muestras obtenidas de pacientes fuera de su cuerpo. Estos análisis se llevan a cabo en entornos de laboratorio controlados, empleando equipos y metodologías especializadas adaptadas a fines de diagnóstico.
Se prevé que el aumento mundial de la población de edad avanzada provoque un aumento notable de la incidencia de enfermedades relacionadas con la edad. Según datos del Departamento de Asuntos Económicos y Sociales de las Naciones Unidas (DAES), en 2022 aproximadamente el 10% de la población mundial tiene 65 años o más. Se prevé que este segmento demográfico se amplíe hasta casi el 12% en 2030 y el 16% en 2050.
| ATRIBUTO | DETALLES |
| Periodo de estudio | 2020-2029 |
| Año base | 2021 |
| Año estimado | 2022 |
| Año pronosticado | 2022-2029 |
| Periodo histórico | 2018-2020 |
| Unidad | Valor (miles de millones de USD) |
| Segmentación | Por producto y servicio, por tecnología, por aplicación, por usuario final, por región |
| Por producto y servicio |
|
| Por tecnología |
|
| Por aplicación | |
| Por región |
|
Con el avance de la edad aumenta la susceptibilidad a diversas enfermedades; en particular, casi el 80% de la población de edad avanzada en los Estados Unidos padece al menos una enfermedad crónica, según los Centros para el Control y la Prevención de Enfermedades (CDC). Una investigación realizada por el Consejo Nacional sobre el Envejecimiento (NCOA) revela que el 94,9% de los adultos de 60 años o más padecen al menos una enfermedad crónica, y el 78,7% padece dos o más simultáneamente.
Los niveles elevados de colesterol en sangre aumentan el riesgo de enfermedades cardíacas, la principal causa de mortalidad, y de accidentes cerebrovasculares, que ocupan el quinto lugar como causa de muerte a nivel mundial. La diabetes, otra enfermedad crónica frecuente entre los ancianos, se debe a irregularidades endocrinas exacerbadas por fluctuaciones hormonales relacionadas con la edad. En consecuencia, se prevé que la creciente demografía geriátrica fomente un aumento en la prevalencia de enfermedades crónicas en todo el mundo, estimulando así el crecimiento dentro del mercado de IVD.
The In-vitro diagnostics market size had crossed USD 95.16 billion in 2020 and will observe a CAGR of more than 3.9% up to 2029 driven by the rising technological advancements.
North America held more than 43% of the In-vitro diagnostics market revenue share in 2021 and will witness expansion. The IVD market in North America is well-established, with the United States serving as the region's primary market. The growing per capita healthcare spending and the region's technologically equipped healthcare infrastructure are driving growth in the North American industry.
The IVD market is characterized by intense competitiveness and is changing rapidly with automation, AI and advanced data analytics. One of the drivers of the In-Vitro diagnostics industry is the shift from centralized to point of care testing.
Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Abbott, and Thermo Fisher Scientific are the leading players in this market. Other players in this market are Johnson & Johnson, Becton, Dickinson and Company, Bio-Rad Laboratories, Sysmex Corporation, bioMérieux, Diasporic, Ortho Clinical Diagnostics, and QIAGEN N.V. are the key players in the In-Vitro Diagnostics/IVD market.
North America held the highest share of the global In-vitro diagnostics market. The IVD market in North America is well-established, with the United States serving as the region's primary market. The growing per capita healthcare spending and the region's technologically equipped healthcare infrastructure are driving growth in the North American industry.
The In-Vitro Diagnostics/IVD market is divided on the basis of Product and service, Technology, application and end user industry. On the basis of Product and service, In-Vitro Diagnostics/IVD market is segmented into Instrument, Kits. In 2020, the reagents & kits sector held the greatest share of the IVD market, accounting for 68.1 percent. The demand for reliable, specific, and speedier detection of chronic illnesses and genetic abnormalities in the early stages, as well as access to a wide range of reagents, are projected to fuel the expansion of this market.
On the basis of Technology, In-Vitro Diagnostics/IVD market is segmented into Immunoassay, MDx, Hematology, Urinalysis. In 2020, the immunoassay/immunochemistry sector will account for 31% of the IVD technologies market. The capacity of immunoassay/immunochemistry technologies to provide faster findings with high sensitivity and accuracy, as well as the rising preference for these technologies in clinical diagnostics over traditional methods, are all contributing to the growth of this market sector.
On the basis of Application, In-Vitro Diagnostics/IVD market is segmented into Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases. Infectious disorders would account for 34.1 percent of the IVD market in 2020. The increased frequency of infectious illnesses and multi-drug-resistant infectious diseases, as well as the growing demand for efficient diagnostic tools for these diseases, can be linked to this segment's substantial share. During the projection period, however, the oncology section is expected to increase at the fastest rate of 6.6 percent. The expanding number of cancer patients throughout the world, the rising need for tailored therapy, and the availability of financing for cancer research are all propelling the industry forward.
On the basis of End use Industry, In-Vitro Diagnostics/IVD market is segmented into Hospitals, Clinical laboratories, Point-of-care testing centers, Academic institutes, Patients, Other. Hospital laboratories will account for 47 percent of the IVD market in 2020, followed by clinical laboratories (23.8 percent) and point-of-care testing centers (13 percent). In hospitals, a variety of diagnostic tests are performed. The acquisition of smaller physician practices and groups by hospitals is becoming a noteworthy trend in the US healthcare business; the IVD market for hospital laboratories will benefit if this trend continues. promoting market expansion.
[caption id="attachment_9537" align="alignleft" width="680"]
Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Abbott, and Thermo Fisher Scientific are the leading players in this market. Other players in this market are Johnson & Johnson, Becton, Dickinson and Company, Bio-Rad Laboratories, Sysmex Corporation, bioMérieux, Diasporic, Ortho Clinical Diagnostics, and QIAGEN N.V. are the key players in the In-Vitro Diagnostics/IVD market.
he In-Vitro Diagnostics/IVD market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
The IVD market in North America is well-established, with the United States serving as the region's primary market. The growing per capita healthcare spending and the region's technologically equipped healthcare infrastructure are driving growth in the North American industry. Different government associations' initiatives are also expected to promote market expansion in the next years.
[caption id="attachment_9538" align="alignleft" width="680"]
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.